Filing Details

Accession Number:
0001181431-12-027953
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2012-05-04 21:56:46
Reporting Period:
2012-05-03
Filing Date:
2012-05-04
Accepted Time:
2012-05-04 21:56:46
Original Submission Date:
2012-05-04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891288 Questcor Pharmaceuticals Inc QCOR Pharmaceutical Preparations (2834) 330476164
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1097955 Md J Mitchell Blutt 1300 North Kellogg Drive
Suite D
Anaheim CA 92807
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-05-03 79,952 $43.95 300,000 No 4 S Indirect See Footnote 2
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote 2
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.70-$44.43, inclusive. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 1 of the Form 4.
  2. The reported securities are directly owned by Consonance Capital Master Account, L.P. and may be deemed beneficially owned by Consonance Capital Advisors, L.P., of which Dr. Blutt is the managing member. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.